FarmaKology Newsletter - Issue #3

News

Lilly and ImmuNext Announce Licensing and Research Collaboration

Eli Lilly and ImmuNext, a developer of immunotherapy compounds for cancer and autoimmune diseases, announced a global licensing and research collaboration worth up to $605 million focused on studying a preclinical novel target that could lead to potential new treatments for autoimmune diseases by regulating immune cell metabolism.

FDA Says Breast Density Must Be Reported to Women During Mammograms

 Women with dense breasts who get mammograms must be told of their higher risk for breast cancer under new rules proposed Wednesday by the U.S. Food and Drug Administration.

Creative Biostructure Unveils Virus Like Particles to Promote The Research in Drug and Antibody Discovery and Characterization

Transgene, BioInvent extend collaboration to develop multifunctional oncolytic viruses for solid tumors

Investors are starting to bet big on psychedelic medicine

Research

Glowing tumors show scientists where cancer drugs are working

Aspirin to fight an expensive global killer infection

Podcast

Listen to Investor-State Arbitration And “Alternative Facts” In Pharmaceutical Marketing and 7 other episodes by Jaharis Podcast On Health & IP. No signup or install required.

Job Opportunities

Pharmacist - Member Support

PHARMACIST- HOSPITAL

PT Weekend Pharmacist

Pharmacist - Floater

Video